REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Betapharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Betapharma S.A. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Betapharma S.A. is based in Ecuador, with the head office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 27, 2004. The total number of employees is currently 37 (2022). In 2022, the company reported a net sales revenue increase of 89.27%. There was a total growth of 9.86% in Betapharma S.A.’s total assets over the same period.

Headquarters
Av. Manuel Cordova Galarza Oe4-175, Inmobiliario Fierro Bldg.
Quito; Pichincha;

Contact Details: Purchase the Betapharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Betapharma S.A. report to view the information.
Outstanding Shares:
Purchase the Betapharma S.A. report to view the information.
Registered Capital:
Purchase the Betapharma S.A. report to view the information.
Incorporation Date:
February 27, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
67%
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Betapharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
89.27%▲
Total operating revenue
89.29%▲
Operating profit (EBIT)
-13.11%▼
EBITDA
-10.36%▼
Net Profit (Loss) for the Period
N/A
Total assets
9.86%▲
Total equity
131.85%▲
Operating Profit Margin (ROS)
14.15%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.26%▲
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo